A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 3, 1999, Pages 899-905

  Daniil, Zoe D ^b   Gilchrist, Frances C ^b   Nicholson, Andrew G ^b   Hansell, David M ^b   Harris, Jessica ^b   Colby, Thomas V ^b   Du Bois, Roland M ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; PREDNISOLONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; FIBROSING ALVEOLITIS; HISTOLOGY; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG FIBROSIS; LUNG FUNCTION; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; THORAX RADIOGRAPHY;

EID: 0032851824     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.3.9903021     Document Type: Article

References (24)

1. Stack, B. H. R., Y. F. J. Choo-Kang, and B. E. Heard, 1972. The prognosis of cryptogenic fibrosing alveolitis. Thorax 17:535-542.
2. Turner-Warwick, M., B. Burrows, and A, Johnson. 1480. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Tharux 35:171-180.
3. Carrington, C. B., E. A. Gaensler, R. E. Coutu, M. X. Fitzgerald, and R. G. Gupta, 1978. Natural history and untreated course of usual and desquamative interstitial pneumonia. N. Engl. J. Med. 298:801-809.
4. Tukiainen, P., E. Taskinen, P. Holsti, O. Korhola, and M. Valle. 1983, Prognosis of cryptogenic fibrosing alveolitis. Thorax .18:349-355.
5. Turner-Warwick, M., B. Burrows, and A. Johnson. 1980. Cryptogenic fibrosing alveolitis: clinical features: response to corticosteroid treatment and its effect on survival. Thorax 35:593-599.
6. Katzenstein, A. A., and J. L. Myers. 1998. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am. J. Respir. Crit. Care Med. 157:1301-1315.
7. Katzenstein, A. A. 1993. Idiopathic interstitial pneumonia: classification and diagnosis. In IAP Monograph Series: Current Topics in Lung Pathology. Williams and Wilkins, Baltimore, MD. 1-33.
8. Liebow, A. A., and C. B. Carrington. 1969. The interstitial pneumonias. In M. Simon, E. J. Potehen, and E. Lemay, editors. Frontiers in Pulmonary Radiology. Grune and Stratton, New York. 102-141.
9. Katzenstein, A. A., J. L. Myers, and M. T. Mazur. 1486. Acute interstitial pneumonia: a clinicopathologic, ultrastructural, and cell kinetic study, Am. J. Surg. Pathol. 10:256-267.
10. Katzenstein, A. A., and R. F. Fiorelli. 1994. Nonspecific interstitial pneumonia/fibrosis: histologic features and clinical significance. Am. J. Surg. Pathol. 18:136-147.
11. Myers, J. L., C. F. Veal, Jr., M. S. Shin, and A. A. Katzenstein. 1987. Respiratory bronchiolitis causing interstitial lung disease: a clinicopathologic study of six eases. Am. Rev. Respir. Dis. 135:880-884.
12. Bjoraker, J. A., J. H., Ryu, M. K. Edwin, J. L. Myers, H. D., Tazelaar, D. R. Schroeder, and K. P. Offord. 1998. Prognostic significance of histological subsets in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 157:199-203.
13. Nagai, S., M. Kitaichi, H. Itoh, T, Izumi, and T.V. Colby. 1998. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur. Respir. J. 12:1010-1019.
14. Quanjer, P. H. 1983. Standardised lung function testing. Clin. Respir. Physiol. 199(Suppl. 5):1-95.
15. Chinet, T., D. Dusser, S. Labrune, M. A. Collignon, J. Chretien, and G. J. Huchon. 1990. Lung function declines in patients with pulmonary sarcoidosis and increased respiratory epithelial permeability to 99mTc DTPA. Am. Rev. Respir. Dis. 141:445-449.
16. Peto, R., M. C. Pike, P. Armilage, N. E. Breslow, D. R. Cox, S. V. Howard, N. Mantel, K. MacPherson, J. Peto, and P. G. Smith. 1977. Design and analysis of randomised clinical trials requiring prolonged observation of each patient: analysis and examples. Br. J. Cancer 35: 1-39.
17. Agusti, C., A. Xaubet, J. Roca, A. Agusti, and R. Rodriguez-Roisin. 1992. Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow-up. Thorax 47:1035-1040.
18. Tung, K. T., A. U. Wells, M. B. Rubens, J. M. E. Kirk, R. M. Du Bois, and D. M. Hansell. 1993. Accuracy of the typical computed tomographic appearances of fibrosing alveolitis. Thorax 48:334-338.
19. Wells, A. U., D. M. Hansell, M. B. Rubens, P. Cullinan, C. M. Black, and R. M. du Bois. 1993. The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis. Am. Rev. Respir. Dis. 148:1076-1082.
20. Wells, A. U., M. B. Rubens, R. M. du Bois, and D. M. Hansell. 1993, Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. Am. Respir. J. 161:1159-1165.
21. Lee, J. S., J. Im, J. M. Ahn, Y. M. Kim, and M. C. Han. 1992. Fibrosing alveolitis: prognostic implication of ground-gtass attenuation at high-resolution CT. Radiology 184:451-454.
22. Terriff, B. A., S. Y. Kwan, M. M. Chan-Yeung, and N. L. Muller. 1992. Fibrosing alveolitis: chest radiography and CT as predictors of clinical and functional impairment at follow-up in 26 patients. Radiology 184: 445-449.
23. Raghu, G., W. J. Depaso, K. Cain, S. P. Hammar, C. E. Wetzel, and D. F. Dreis. 1991. Azathioprine combination with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. Am. Rev. Respir. Dis. 144: 291-296.
24. Johnson, M. A., S. Kwan, N. J. Snell, A. J. Nunn, J. H. Darbyshire, and M. Turner-Warwick. 1989. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax 44:280-288.